Hodgkin's Lymphoma Survivors Face Higher Cardiovascular Risks

Share this content:
Physicians and patients should be aware of the persistently increased risk of cardiovascular diseases throughout life after Hodgkin's lymphoma.
Physicians and patients should be aware of the persistently increased risk of cardiovascular diseases throughout life after Hodgkin's lymphoma.

Physicians and patients should be aware of the persistently increased risk of cardiovascular diseases throughout life after Hodgkin's lymphoma, according to a report published in JAMA Internal Medicine.

Flora van Leeuwen, Ph.D., of the Netherlands Cancer Institute in Amsterdam, and colleagues examined the medical records of 2,524 Dutch patients who were treated for Hodgkin's lymphoma between 1965 and 1995, and were diagnosed before the age of 51. The researchers tracked them for as long as 40 years.

RELATED: Radiotherapy, No Treatment After ABVD Effective for Early-Stage Hodgkin's Lymphoma

The research uncovered a four- to seven-fold higher risk of coronary heart disease or heart failure in these Hodgkin's survivors compared to people who had never had the disease.

"The results of our study may direct guidelines for follow-up of patients with Hodgkin's lymphoma," the authors write.

Reference

  1. Nimwegene, Frederika A. van, MSc, et al. "Cardiovascular Disease After Hodgkin Lymphoma Treatment: 40-Year Disease Risk." JAMA Internal Medicine. doi:10.1001/jamainternmed.2015.1180. [epub ahead of print]. April 27, 2015.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters